Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11672776
Multi-arm polymeric alkanoate conjugates
granted -
US 11674121
Platform for generating safe cell therapeutics
granted -
US 11672775
Treprostinil prodrugs
granted -
US 11672791
Tyrosine kinase inhibitors
granted -
US 11672793
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 11672771
Beta-alethine, immune modulators, and uses thereof
granted -
US 2023174645
ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS
granted -
US 11667911
Use of exonucleases to improve CRISPR/CAS-mediated genome editing
granted -
US 11666536
Extended release compositions comprising pyridostigmine
granted -
US 11666557
Triazolone compounds and uses thereof
granted -
US 11666663
Hexameric tetrahedral RNA nanostructures
granted -
US 11667701
Anti-PfRH5 antibodies and antigen-binding fragments thereof
granted -
US 11667717
Antibodies binding to human IL-4R, preparation method therefor and use thereof
granted -
US 11667784
Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the
granted -
US 11666547
Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)
granted -
US 11667920
Methods for treating brain injury
granted -
US 11668704
Degradation preventing means for immunoassay reagent containing insoluble carrier particles
granted -
US 11666528
Drug implants containing enzalutamide and methods of use thereof
granted -
US 11666660
Glycan-dependent immunotherapeutic molecules
granted -
US 11667662
Modulators of 5′-nucleotidase, ecto and the use thereof
granted -
US 11667924
Increasing levels of nicotinic alkaloids in plants
granted -
US 11667612
Compositions and methods for delivering pharmaceutical agents
granted -
US 11666596
Nucleotide, polypeptide and applications thereof
granted -
US 11670409
Method and apparatus for providing a pharmacokinetic drug dosing regiment
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.